Quantcast

Latest recombinant DNA Stories

2014-09-08 08:28:59

REHOVOT, Israel, September 8, 2014 /PRNewswire/ -- CollPlant (TASE: CLPT), a developer and manufacturer of human collagen-based medical products has announced that Dr. Nadav Orr has been appointed Vice President of Research & Development, effective September 7, 2014. Dr. Nadav Orr brings over 15 years of experience in research and development, including 9 years in the development of Biosurgery products. Before joining Collplant, Nadav served as an Associate...

2014-06-18 23:16:14

Bacterial recombinant protein expression is now available as a service at Maine Biotechnology Services. When MBS develops recombinant antigen for a hybridoma development, the end use application of the antibodies is considered during every phase of antigen production. Portland, Maine (PRWEB) June 18, 2014 Maine Biotechnology Services is announcing the addition of Bacterial Recombinant Protein Expression and Purification services to compliment our complete antibody service offering, adding...

2014-05-30 23:06:45

Dr. Igor Fisch to Present Data on Using Genome Engineering and the Selexis SURE CHO-Mplus Libraries for Optimal Transgene Expression and Recombinant Protein Production Geneva, Switzerland (PRWEB) May 30, 2014 Selexis SA, a serial innovation company with proven technologies for biologic drug discovery and mammalian cell line development announced today the Company’s CEO, Igor Fisch, Ph.D., will present “Genome Engineering and SURE CHO-Mplus Libraries™ for Optimal Transgene Expression...

2014-05-20 23:00:29

The growth of Protein Expression market will be governed by the increasing intensity in research and the rise of biologics and proteomics markets. http://www.marketsandmarkets.com/Market-Reports/protein-expression-market-180323924.html (PRWEB) May 21, 2014 The “Protein Expression Market by Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast), by Products (Expression Vector, Service, Reagent), by Application (Industrial, Therapeutic) by End User (Pharmaceutical, Biotechnology,...

2014-03-26 23:24:54

Dr. Pierre-Allain Girod to Present on Data on Engineering CHO Cell Lines for Enhanced Production of Monoclonal Antibodies and Fc:Fusion Proteins Geneva, Switzerland (PRWEB) March 26, 2014 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today the Company’s chief scientific officer, Pierre-Allain Girod, Ph.D., will present, “Selexis SURE CHO-Mplus™...

2014-01-09 08:26:28

SAN DIEGO, Jan. 9, 2014 /PRNewswire/ -- Ajinomoto Althea, Inc., a leading Contract Manufacturing Organization providing development and manufacturing services for biotechnology and pharmaceutical companies, announced today its new product offering, Corynex®, to produce secreted, soluble, properly folded proteins from microbial fermentation. In addition, the company announced the successful finalization of the production process for a therapeutic protein primed to enter a Phase I...

2013-12-19 23:23:22

St. George’s to Utilize DNA2.0’s GeneGPS® Expression Technology to Increase Protein Expression in Tobacco for the Production of Therapeutic Antibodies Menlo Park, Calif. (PRWEB) December 19, 2013 DNA2.0 has entered into a research collaboration with the Infection and Immunity Research Centre at St. George’s, University of London, to support the development of plant-based biopharmaceuticals. Professor Julian Ma and his research group at St. George’s have made significant...

2013-12-17 23:04:19

CSO to Present Data on the Recently Launched SURE CHO-Mplus™ Libraries Geneva, Switzerland (PRWEB) December 17, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs announced today data from the Company’s SURE CHO-Mplus™ Libraries will be presented at the 13th Annual PepTalk Conference, January 13-17, 2014 at the Renaissance Hotel & Palm Springs...

2013-10-24 23:21:55

Dr. Igor Fisch to Present Data on Using the SURE CHO-Mplus Combinatorial Library to Address a Broad Range of Protein Production Bottlenecks Geneva, Switzerland (PRWEB) October 24, 2013 Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs, announced today the Company’s president and CEO, Igor Fish, Ph.D., will present, “Selexis SURE CHO-Mplus™ Libraries: Custom...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related